Next Generation News and Research

RSS

New research tool replicates extreme environmental conditions to help understand the human body's response to everyday stresses

A new research tool will allow University of Oregon scientists to replicate an extreme range of environmental conditions in their quest to test and understand the human body's response to everyday stresses.

21 Jun 2005

Cardiovascular researchers at the University of Oregon use new environmental chamber to investigate the body's response to stress

19 Jun 2005

Fusing physics with medicine to fight cancer

Everyone’s lives are touched by cancer - it is a disease that affects 1 in 3 of us throughout our lifetime. Future developments that lead to earlier diagnosis and more effective therapy lie in further successful collaboration between high energy physicists and the healthcare industry.

2 May 2005

Health care inequalities in the UK no better under New Labour

Despite government rhetoric about its commitment to tackle the problem, health inequalities continue to widen in the UK, and under New Labour the promises made do not compare with reality.

1 May 2005

New centre launched to investigate link between human sugars and disease

A multidisciplinary centre launched today will promote a far broader understanding of the role sugars play in human disease, scientists say.

28 Apr 2005

Propensity for obesity, diabetes may occur in utero

The adage "You are what you eat" should be rephrased to include "and so are your children," based on metabolic research pioneered by researchers at the University at Buffalo.

22 Apr 2005

Child health teacher numbers at worrying levels

Concerns over the future of children's health care in the UK are being raised as new research shows the numbers of clinical teachers in this field have dropped dramatically in recent years.

20 Apr 2005

Germany leads the way with e-health

Germany is poised to introduce its next generation e-health card in 2006. The new version, set to replace the existing insurance card – holding only the patient’s name, address and insurance number – will be the latest example of smart card technology to hit the market in Europe. It will be able to store prescription information and might even be used as the standard card for a digital signature – the key to modern eGovernment applications.

12 Apr 2005

Bionic eyes from Stanford

Stanford physicists and eye doctors have teamed up to design a "bionic eye," of sorts. On Feb. 22 in the Journal of Neural Engineering, Daniel Palanker, Alexander Vankov and Phil Huie from the Department of Ophthalmology and the Hansen Experimental Physics Laboratory and Stephen Baccus from the Department of Neurobiology published a design of an optoelectronic retinal prosthesis system that can stimulate the retina with resolution corresponding to a visual acuity of 20/80

4 Apr 2005

Need for pediatricians to partner with community-based organizations

Pediatricians must look beyond the walls of the examining room and into their own communities to understand and confront the socioeconomic and environmental threats to the health of children and adolescents, such as poor nutrition, exposure to violence, and substance abuse.

4 Apr 2005

Healthcare information system vendors focus on developing business with new clients

The healthcare industry in Europe is fragmented with several vendors controlling different niche segments. Early technology vendors that implemented legacy systems still have a hold on pockets of provider groups both in the primary, secondary and acute care segments, simply because the end users do not have the resources for expensive upgrades.

29 Mar 2005

No serious adverse events found with next-generation smallpox vaccine

Interim data from a phase I/II clinical trial of a next-generation vaccine for smallpox suggest that the vaccine may provide immunity and thus far the trial has been without any serious adverse events.

22 Mar 2005

Major milestone in identifying and creating a register of genes involved in multiple sclerosis

For the first time in this disease area, researchers at the SGI have identified 80 genes involved in the inflammatory and neuro-degenerative pathways of MS, based on a 40% genome scan comparing the genetic profile of a total of 1,800 people with MS and healthy individuals in different populations.

17 Mar 2005

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

The nation’s frontline HIV medical providers are calling for an end to waiting lists for essential anti-AIDS drugs that patients need in order to live.

8 Mar 2005

VIRxSYS novel HIV gene therapy yields exciting results

VIRxSYS Corporation reports unexpected and unprecedented findings in its ongoing Phase I clinical trial of its VRX496 therapy in patients with HIV.

28 Feb 2005

Deaths from mesothelioma will peak within ten years in the UK

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer.

17 Feb 2005

Achieva 3T MR Scanner launched officially launched

The first 'next generation' MRI (magnetic resonance imaging) body scanner in the world will be officially launched at Hope Hospital later this week (Friday 18th February).

15 Feb 2005

Survey finds online health information poised to become important resource for seniors, but not there yet

As the Internet becomes an increasingly important resource for informing decisions about health and health care options, a new national survey of older Americans by the Kaiser Family Foundation finds that less than a third (31%) of seniors (age 65 and older) have ever gone online, but that more than two-thirds (70%) of the next generation of seniors (50-64 year-olds) have done so.

12 Jan 2005

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.

9 Jan 2005

FDA approves Abraxane for metastatic breast cancer

American Pharmaceutical Partners, Inc. and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) has approved Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in metastatic breast cancer.

9 Jan 2005